Sail Biomedicines’ experimental programmable RNA technology, called Endless RNA or eRNA, appears to result in long-lasting production of the…
Articles by Margarida Maia, PhD
Taking CFTR modulators as a child may make boys and girls with cystic fibrosis (CF) grow about a third…
Structural improvements in the airways and sinuses of adults with cystic fibrosis (CF) were seen on CT scans…
Health Canada has extended its approval of Kalydeco (ivacaftor) to treat children as young as 2 months and weighing…
Kaftrio (elexacaftor/tezacaftor/ivacaftor) — known as Trikafta in the U.S. — brings broad benefits in the form of better lung…
Loss of bladder or bowel control is common among adults with cystic fibrosis (CF), and such incontinence problems may…
An MRI technique revealed signs of reversible bronchiectasis (widened and inflamed airways) in more than one in three people with…
Six months of treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor), sold as Trikafta in the U.S., leads to increases in body mass…
One month of treatment with Trikafta, a triple combo of elexacaftor, tezacaftor, and ivacaftor, helped to clear mucus from…
Trikafta, a combination of elexacaftor, tezacaftor, and ivacaftor, lowered the number of Pseudomonas aeruginosa bacteria in the nose and…